Skip to main content
. 2017 Mar 27;2017(3):CD004752. doi: 10.1002/14651858.CD004752.pub2

Summary of findings for the main comparison. Glucocorticoid supplementation versus placebo for IVF or ICSI.

Glucocorticoid supplementation versus placebo for IVF or ICSI
Patient or population: Patients undergoing IVF or ICSI
 Settings: Infertility clinics in University/Teaching hospitals
 Intervention: Glucocorticoid supplementation during ovarian stimulation
 Comparison: Placebo
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) No of Participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
Placebo Glucocorticoid supplementation
Live birth rate 147 per 1000 157 per 1000 
 (72 to 308) OR 1.08 
 (0.45 to 2.58) 212
 (2 studies) ⊕⊕⊝⊝
 low1  
Clinical pregnancy rate per woman/couple 236 per 1000 343 per 1000 
 (233 to 473) OR 1.69 
 (0.98 to 2.90) 310
 (2 studies) ⊕⊕⊝⊝
 low1  
Multiple pregnancy rate per woman/couple Only one event (in the glucocorticoid group) OR 3.32 
 (0.12 to 91.60) 20
 (1 study) ⊕⊝⊝⊝
 very low1,2  
Miscarriage rate per woman See footnote3 OR 1.00 (0.05 to 18.57) 20
 (1 study) ⊕⊝⊝⊝
 very low1,2  
OHSS per woman Not reported in the included studies      
Side‐effects per woman Not reported in the included studies      
*The basis for the assumed risk is the median risk in the control groups. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: Confidence interval; OR: Odds ratio.
GRADE Working Group grades of evidence
 High quality: Further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: We are very uncertain about the estimate.

1 Downgraded two levels for very serious imprecision: low number of events and wide confidence intervals

2 Downgraded one level for serious risk of bias: method of sequence generation not described

3 Data supplied by trial authors were incomplete. They reported 3 clinical pregnancies and 2 live births in each group, and one miscarriage in the placebo group. We decided to impute a second miscarriage, in the glucocorticoid group, although we accept that this could have been a stillbirth.